The retinoic acid receptor beta (Rarb) region of Mmu14 is associated with prion disease incubation time in mouse

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Grizenkova, Julia ^a   Akhtar, Shaheen ^a   Collinge, John ^a   Lloyd, Sarah E ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CLUSTERIN; GENE PRODUCT; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PRION PROTEIN; RETINOIC ACID RECEPTOR BETA; STATHMIN LIKE 2; THYROID HORMONE RECEPTOR BETA; UNCLASSIFIED DRUG; CLU PROTEIN, MOUSE; MESSENGER RNA; RETINOIC ACID RECEPTOR; SIGNAL PEPTIDE; STMN2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; INCUBATION TIME; INTRON; LINKAGE ANALYSIS; MOUSE; NONHUMAN; PRION DISEASE; PROMOTER REGION; QUANTITATIVE TRAIT LOCUS MAPPING; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; CREUTZFELDT JAKOB DISEASE; DISEASE MODEL; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHENOTYPE; PRION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

BOVINAE; MUS;

ANIMALS; CLUSTERIN; CREUTZFELDT-JAKOB SYNDROME; DISEASE MODELS, ANIMAL; GENOME-WIDE ASSOCIATION STUDY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRION DISEASES; PRIONS; RECEPTORS, RETINOIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 78650119765     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015019     Document Type: Article

References (34)

1. Collinge J (2001) Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24: 519-550.
2. Collinge J, Palmer MS, Dryden AJ (1991) Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 337: 1441-1442.
3. Mead S, Stumpf MP, Whitfield J, Beck J, Poulter M, et al. (2003) Balancing selection at the prion protein gene consistent with prehistoric kuru-like epidemics. Science 300: 640-643.
4. Palmer MS, Dryden AJ, Hughes JT, Collinge J (1991) Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352: 340-342.
5. Collinge J (2005) Molecular neurology of prion disease. J Neurol Neurosurg Psychiatry 76: 906-919.
6. Mead S, Poulter M, Uphill J, Beck J, Whitfield J, et al. (2009) Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study. Lancet Neurol 8: 57-66.
7. Moore RC, Hope J, McBride PA, McConnell I, Selfridge J, et al. (1998) Mice with gene targetted prion protein alterations show that Prnp, Sinc and Prni are congruent. Nat Genet 18: 118-125.
8. Westaway D, Goodman PA, Mirenda CA, McKinley MP, Carlson GA, et al. (1987) Distinct prion proteins in short and long scrapie incubation period mice. Cell 51: 651-662.
9. Carlson GA, Goodman PA, Lovett M, Taylor BA, Marshall ST, et al. (1988) Genetics and polymorphism of the mouse prion gene complex: control of scrapie incubation time. Mol Cell Biol 8: 5528-5540.
10. Carlson GA, Ebeling C, Torchia M, Westaway D, Prusiner SB (1993) Delimiting the Location of the Scrapie Prion Incubation Time Gene on Chromosome 2 of the Mouse. Genetics 133: 979-988.
11. Lloyd S, Onwuazor ON, Beck J, Mallinson G, Farrall M, et al. (2001) Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc Natl Acad Sci U S A 98: 6279-6283.
12. Lloyd S, Uphill JB, Targonski PV, Fisher E, Collinge J (2002) Identification of genetic loci affecting mouse-adapted bovine spongiform encephalopathy incubation time in mice. Neurogenetics 4: 77-81.
13. Stephenson DA, Chiotti K, Ebeling C, Groth D, DeArmond SJ, et al. (2000) Quantitative trait loci affecting prion incubation time in mice. Genomics 69: 47-53.
14. Manolakou K, Beaton J, McConnell I, Farquar C, Manson J, et al. (2001) Genetic and environmental factors modify bovine spongiform encephalopathy incubation period in mice. Proc Natl Acad Sci U S A 98: 7402-7407.
15. Moreno CR, Lantier F, Lantier I, Sarradin P, Elsen JM (2003) Detection of new quantitative trait loci for susceptibility to transmissible spongiform encephalopathies in mice. Genetics 165: 2085-2091.
16. Lloyd SE, Maytham EG, Pota H, Grizenkova J, Molou E, et al. (2009) HECTD2 is associated with susceptibility to mouse and human prion disease. PLoS Genet 5: e1000383.
17. Lloyd SE, Maytham EG, Grizenkova J, Hummerich H, Collinge J (2009) A Copine family member, Cpne8, is a candidate quantitative trait gene for prion disease incubation time in mouse. Neurogenetics 11: 185-191.
18. Valdar W, Solberg LC, Gauguier D, Burnett S, Klenerman P, et al. (2006) Genome-wide genetic association of complex traits in heterogeneous stock mice. Nat Genetics 38: 879-887.
19. Brundin P, Melki R, Kopito R (2010) Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 11: 301-307.
20. Parkin ET, Watt NT, Hussain I, Eckman EA, Eckman CB, et al. (2007) Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein. Proc Natl Acad Sci U S A.
21. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, et al. (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41: 1088-1093.
22. Lambert JC, Heath S, Even G, Campion D, Sleegers K, et al. (2009) Genomewide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41: 1094-2000.
23. Xu F, Karnaukhova E, Vostal JG (2008) Human cellular prion protein interacts directly with clusterin protein. Biochim Biophys Acta 1782: 615-620.
24. Sasaki K, Doh-ura K, Ironside JW, Iwaki T (2002) Increased clusterin (apolipoprotein J) expression in human and mouse brains infected with transmissible spongiform encephalopathies. Acta Neuropathol (Berl) 103: 199-208.
25. Kempster S, Collins ME, Aronow BJ, Simmons M, Green RB, et al. (2004) Clusterin shortens the incubation and alters the histopathology of bovine spongiform encephalopathy in mice. Neuroreport 15: 1735-1738.
26. O'Shea M, Maytham EG, Linehan JM, Brandner S, Collinge J, et al. (2008) Investigation of Mcp1 as a Quantitative Trait Gene for Prion Disease Incubation Time in Mouse. Genetics 180: 559-566.
27. Hitzemann B, Dains K, Kanes S, Hitzemann R (1994) Further-Studies on the Relationship Between Dopamine Cell-Density and Haloperidol-Induced Catalepsy. J Pharm Exp Ther 271: 969-976.
28. Lander ES, Botstein D (1989) Mapping mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics 121: 185-199.
29. Darvasi A, Soller M (1992) Selective Genotyping for Determination of Linkage Between A Marker Locus and A Quantitative Trait Locus. Theor Appl Genet 85: 353-359.
30. Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, et al. (2010) Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease. JAMA 303: 1832-1840.
31. Yamazaki K, Yamada E, Kanaji Y, Yanagisawa T, Kato Y, et al. (2003) Stimulation of cellular prion protein expression by TSH in human thyrocytes. Biochem Biophys Res Commun 305: 1034-1039.
32. Cabral ALB, Lee KS, Martins VR (2002) Regulation of the cellular prion protein gene expression depends on chromatin conformation. J Biol Chem 277: 5675-5682.
33. Bate C, Langeveld J, Williams A (2004) Manipulation of PrP(res) production in scrapie-infected neuroblastoma cells. J Neurosci Methods 138: 217-223.
34. Mellon PL, Windle JJ, Goldsmith PC, Padula CA, Roberts JL, et al. (1990) Immortalization of Hypothalamic Gnrh Neurons by Genetically Targeted Tumorigenesis. Neuron 5: 1-10.